Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

26. Share-Based Payment

v3.19.1
26. Share-Based Payment
12 Months Ended
Dec. 31, 2018
Share-based Payment  
Share-Based Payment

Note 26 — Share-Based Payment

 

On February 25, 2010, the Company’s board of directors authorized and issued 20,000 stock options, each option to purchase one ordinary share of the Company, to directors and consultants of the Company.  In November 2010, September 2015 and April 2016, the Company’s board of directors authorized to reserve an additional 200,000, 280,000 and 200,000 stock options, respectively, for issuance to directors and consultants of the Company from time to time, bringing the total authorized to an aggregate of 700,000 stock options.

 

In January, April and October 2016, the Company’s board of directors granted 150,000 stock options to two directors, 140,000 stock options two officers, and 23,000 stock options to two external consultants.

 

In May, 2017, one consultant to the Company and various employees of the subsidiaries elected to exercise the stock options vested. There were a total of 2,900 options exercised.

 

The following table summarizes the stock option activity for the years ended December 31, 2018, 2017 and 2016:

 

    Number of
shares
    Weighted
average
exercise price
per share
    Weighted
average
remaining
contractual
term
(in years)
    Aggregate
intrinsic
value
 
Outstanding at January 1, 2016     202,500     $ 2.759       5.00     $ 413,693  
Granted     313,000                   329,871  
Exercised                        
Cancelled     (31,250 )                  
Outstanding at December 31, 2016     484,250     $ 1.132       4.69     $ 743,564  
Granted                        
Exercised     (2,900 )                  
Cancelled     (7,500 )                 (2,400 )
Outstanding and exercisable at December 31, 2017     473,850     $ 1.132       3.85     $ 741,164  
Granted                        
Exercised                        
Cancelled     (655 )                    
Outstanding and exercisable at December 31, 2018     473,195     $ 1.132       2.85     $ 741,164  

 

The following table summarizes the unvested stock option activity during the period from January 1, 2016 to December 31, 2018:

 

    Number of shares  
Unvested January 1, 2016     134,302  
Granted     313,000  
Vested     (266,837 )
Cancelled     (31,250 )
Unvested December 31, 2016     149,215  
Granted      
Vested     (99,249 )
Cancelled     (7,500 )
Unvested December 31, 2017     42,466  
Granted      
Vested     (28,375 )
Cancelled     (655 )
Unvested December 31, 2018     13,436  

 

The fair value assigned to the vested increments of these awards was estimated at the grant date of the stock options using the Black-Scholes option-pricing model with the following assumptions:

 

    Year ended
December 31,
2016
 
       
Stock price     $1.80 - $3.55  
Risk-free interest rate     0.94% - 2.10%  
Expected term (in years)     5.0  
Weighted average expected stock price volatility     34.28%  
Expected dividend yield     0%  
Weighted average grant-date fair value of options granted   $ 1.0539  

 

For the years ended December 31, 2018 and 2017, there were no stock options granted. For the year ended December 31, 2016, Management used the following assumptions for the Black-Scholes inputs: On the option valuation date, the current stock price of the Company was used for determining the fair value of the Company’s stock based on the closing price of common stock on the valuation date. The expected dividend rate of 0% is based on Management’s plan of operations. The risk-free interest rate is based on the U.S. Treasury 5-year Treasury Bill on the date of measurement. The Company’s historical stock price was used to determine the expected volatility. The Company expects that no options will be forfeited.

  

Share-based compensation expense from stock options totaled $20,210, $95,419, and $370,040 for the years ended December 31, 2018, 2017 and 2016, respectively. Share-based compensation expense from stock options to be expensed in future periods is expected to be $6,989 for the year ending December 31, 2019.